**Zimmer Biomet Holdings: A Resilient Player in the Medical Products and Equipment Industry**

As of the Fortune 2024 ranking, Zimmer Biomet Holdings secured the 484th spot among the top 1000 companies. This notable achievement is a testament to the company's steady growth and commitment to excellence in the health care sector, specifically in the medical products and equipment industry.

Headquartered in Warsaw, Indiana, Zimmer Biomet Holdings is a publicly traded company (NYSE: ZBH) that has established itself as a major player in the healthcare industry. Under the leadership of CEO Ivan Tornos, the company has made significant strides in recent years. Although Tornos is not the founder of the company, his leadership has been instrumental in driving Zimmer Biomet's success.

One of the key indicators of the company's performance is its impressive market value, which stood at $27,116.8 million as of March 28, 2024. This represents a substantial presence in the global market, with a significant impact on the medical products and equipment industry. The company's market capitalization has been updated to $27,117 million as of June 4, 2024.

Zimmer Biomet's revenue for the period under review was $7,394.2 million, representing a 4.3% increase from the previous year. This growth in revenue is a positive indicator of the company's ability to adapt to changing market conditions and capitalize on emerging trends in the healthcare industry. Moreover, the company's profits for the period were $1,024 million, marking a significant 342.5% increase from the previous year. This substantial growth in profits is a testament to the company's effective cost management and strategic investment in research and development.

The company's asset base also reflects its growth and expansion, with total assets valued at $21,496.9 million. With a workforce of approximately 18,000 employees, Zimmer Biomet is a significant employer in the healthcare industry. However, the company did not experience growth in jobs during the period under review.

In terms of ranking, Zimmer Biomet Holdings gained 25 spots in the Fortune 1000 list, moving from its previous position to secure the 484th spot. This upward movement in ranking is a positive indicator of the company's growth and resilience in the face of industry challenges. Furthermore, the company made its debut as a newcomer to the Fortune 500 list, a notable achievement that reflects its growing influence in the global market.

While Zimmer Biomet Holdings is not currently recognized as one of the World's Most Admired Companies or one of the Best Companies to Work For, its recent performance and growth trajectory suggest that it may be a strong contender for these accolades in the future.

In conclusion, Zimmer Biomet Holdings' strong performance in the Fortune 2024 ranking is a testament to the company's commitment to excellence in the medical products and equipment industry. With a strong leadership team, a growing market presence, and a significant workforce, the company is poised for continued growth and success in the years to come.